Dow Down 0.25% Nasdaq Down 0.26%

Endocyte, Inc. (ECYT)

-NasdaqGS
6.98 0.32(4.80%) Aug 28, 4:00PM EDT
Prev Close:6.66
Open:6.60
Bid:6.64 x 600
Ask:7.47 x 1200
1y Target Est:13.00
Beta:0.98
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:6.52 - 7.15
52wk Range:5.91 - 33.70
Volume:1,972,449
Avg Vol (3m):1,057,360
Market Cap:290.02M
P/E (ttm):N/A
EPS (ttm):-0.48
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for ECYT

Comparison

Symbol% ChgMkt Cap
ECYTUp 4.80%290.02M
NKTR1.82B
RHHBY248.42B
SNSS470.24M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):2.76
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.08
Quarterly EPS Est (Sep-14) :-0.18
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Endocyte, Inc., a biopharmaceutical company, develops targeted therapies for the treatment of cancer and inflammatory diseases in the United States. The company uses its proprietary technology to create novel small molecule drug conjugates (SMDCs)... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback